Literature DB >> 31002830

Trends in cervical cancer incidence rates by age, race/ethnicity, histological subtype, and stage at diagnosis in the United States.

Farhad Islami1, Stacey A Fedewa2, Ahmedin Jemal2.   

Abstract

Recent trends of cervical cancer incidence by histology and age in the United States (U.S.) have not been reported. We examined contemporary trends in cervical squamous cell carcinoma (SCC) and adenocarcinoma (AC) incidence rates in the U.S. by age group, race/ethnicity, and stage at diagnosis after accounting for hysterectomy. Incidence data (1999-2015) were obtained from the U.S. Cancer Statistics Incidence Analytic Database. Hysterectomy prevalence was estimated using National Health Interview Survey data (2000-2015). Overall SCC incidence rates continued to decrease in all racial/ethnic groups except among non-Hispanic whites in whom rates stabilized in the 2010s, largely driven by stable trends in ages <50 years and a slower pace of decrease in ages 50-59 years. After a stable trend between 1999 and 2002, AC incidence rates among non-Hispanic whites rose during 2002-2015 (1.3% per year), mostly due to increases in ages 40-49 (4.4% annually since 2004) and 50-59 years (5.5% annually since 2011). Overall AC incidence rates during 1999-2015 decreased in blacks and Hispanics but were stable in Asian/Pacific Islanders; in all these race/ethnicities, rates were generally stable in ages <50 years but decreasing in older ages. Rates of distant stage cervical SCC and AC among non-Hispanic whites increased in several age groups but were generally stable in non-whites. Increasing or stabilized incidence trends for AC and attenuation of earlier declines for SCC in several subpopulations underscore the importance of intensifying efforts to reverse the increasing trends and further reduce the burden of cervical cancer in the U.S.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; Cervical cancer; Human papillomavirus; Screening; Squamous cell carcinoma

Mesh:

Year:  2019        PMID: 31002830     DOI: 10.1016/j.ypmed.2019.04.010

Source DB:  PubMed          Journal:  Prev Med        ISSN: 0091-7435            Impact factor:   4.018


  28 in total

Review 1.  The changing landscape of cancer in the USA - opportunities for advancing prevention and treatment.

Authors:  Farhad Islami; Rebecca L Siegel; Ahmedin Jemal
Journal:  Nat Rev Clin Oncol       Date:  2020-05-28       Impact factor: 66.675

2.  Negative loop electrosurgical excision procedure (LEEP) following cervical biopsy diagnosis of high grade squamous intraepithelial lesion.

Authors:  Fatima Zahra Aly; Alyaa Irhayyim; Jacquelyn Knapik; Robert Klein
Journal:  Int J Clin Exp Pathol       Date:  2021-12-15

3.  Exploring novel strategies for social media HPV vaccine information.

Authors:  Erika L Thompson; Annalynn M Galvin; Ashvita Garg; Jonathan D Moore; Dana M Litt
Journal:  Hum Vaccin Immunother       Date:  2021-11-04       Impact factor: 3.452

4.  Socioeconomic and Racial Determinants of Brachytherapy Utilization for Cervical Cancer: Concerns for Widening Disparities.

Authors:  David Boyce-Fappiano; Kevin A Nguyen; Olsi Gjyshi; Gohar Manzar; Chike O Abana; Ann H Klopp; Mitchell Kamrava; Peter F Orio; Nikhil G Thaker; Firas Mourtada; Puja Venkat; Albert J Chang
Journal:  JCO Oncol Pract       Date:  2021-09-22

5.  US hysterectomy prevalence by age, race and ethnicity from BRFSS and NHIS: implications for analyses of cervical and uterine cancer rates.

Authors:  Emily E Adam; Mary C White; Mona Saraiya
Journal:  Cancer Causes Control       Date:  2021-09-21       Impact factor: 2.506

6.  Development and Validation of an Immune-Related Prognostic Signature in Cervical Cancer.

Authors:  Rongjia Su; Chengwen Jin; Hualei Bu; Jiangdong Xiang; Lina Zhou; Chengjuan Jin
Journal:  Front Oncol       Date:  2022-05-16       Impact factor: 5.738

7.  Recent Trends in Squamous Cell Carcinoma of the Anus Incidence and Mortality in the United States, 2001-2015.

Authors:  Ashish A Deshmukh; Ryan Suk; Meredith S Shiels; Kalyani Sonawane; Alan G Nyitray; Yuxin Liu; Michael M Gaisa; Joel M Palefsky; Keith Sigel
Journal:  J Natl Cancer Inst       Date:  2020-08-01       Impact factor: 13.506

8.  Quality over quantity: human papillomavirus vaccine information on social media and associations with adult and child vaccination.

Authors:  Annalynn M Galvin; Ashvita Garg; Jonathan D Moore; Dana M Litt; Erika L Thompson
Journal:  Hum Vaccin Immunother       Date:  2021-06-04       Impact factor: 4.526

9.  Incidence Trends and Burden of Human Papillomavirus-Associated Cancers Among Women in the United States, 2001-2017.

Authors:  Ashish A Deshmukh; Ryan Suk; Meredith S Shiels; Haluk Damgacioglu; Yueh-Yun Lin; Elizabeth A Stier; Alan G Nyitray; Elizabeth Y Chiao; Gizem S Nemutlu; Jagpreet Chhatwal; Kathleen Schmeler; Keith Sigel; Kalyani Sonawane
Journal:  J Natl Cancer Inst       Date:  2021-06-01       Impact factor: 13.506

10.  Impact of Screening Modality on the Detection of Cervical Adenocarcinoma In Situ and Adenocarcinoma.

Authors:  Ran C Zhang; Nujsaubnusi C Vue; Lisa U Obasi; Rachel I Vogel; Amar T Subramanian; Mahmoud A Khalifa; Buvana R Reddy; Britt K Erickson
Journal:  J Low Genit Tract Dis       Date:  2021-10-01       Impact factor: 3.842

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.